Exact Mass: 590.1694214
Exact Mass Matches: 590.1694214
Found 110 metabolites which its exact mass value is equals to given mass value 590.1694214
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mulberrofuran M
Mulberrofuran M is found in fruits. Mulberrofuran M is a constituent of Morus alba (white mulberry). D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists Constituent of Morus alba (white mulberry). Mulberrofuran M is found in fruits. D004791 - Enzyme Inhibitors
Maysin 3'-methyl ether
Maysin 3-methyl ether is found in cereals and cereal products. Maysin 3-methyl ether is isolated from corn silk (Zea mays). Isolated from corn silk (Zea mays). Maysin 3-methyl ether is found in cereals and cereal products and corn.
4'-Hydroxyanigorootin
4-Hydroxyanigorootin is found in fruits. 4-Hydroxyanigorootin is a constituent of the rhizomes of Musa acuminata (dwarf banana). Constituent of the rhizomes of Musa acuminata (dwarf banana). 4-Hydroxyanigorootin is found in fruits.
Corrigendum
Grape seed extract
Lusutrombopag
B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics C78275 - Agent Affecting Blood or Body Fluid
Matterionate B
12-Dihydrodalbin
4-[4-(3-Methyl-2,3-dihydroxybutoxy)-5,5-dimethylspiro[7H-furo[3,2-g][1]benzopyran-7,2-[1,3]dioxolane]-4-ylmethoxy]-7H-furo[3,2-g][1]benzopyran-7-one
Amorphigenol O-glucoside
Mulberrofuran M
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D004791 - Enzyme Inhibitors
3-deoxy-4,7-di-O-(alphaD-galactopyranosyluronic acid)-beta-D-manno-2-octulopyranosic acid
(2,2-Bianthracene)-8,8(5H,5H)-dione, 6,6,7,7-tetrahydro-1,1,5,6,6,9,9-heptahydroxy-3,3-dimethoxy-6,6-dimethyl-
4-[(6-O-[5-O-(4-hydroxybenzoyl)-beta-D-apiofuranosyl]-beta-D-glucopyranosyl)oxy]-5-methyl-2H-1-benzopyran-2-one|diosfeboside B
O-alpha-L-arabinofuranosyl-(1<*>3)-O-(2-O-trans-feruloyl-alpha-L-arabinofuranosyl)-(1<*>5)-alpha-L-arabinofuranose|O-alpha-L-arabinofuranosyl-(1[*]3)-O-(2-O-trans-feruloyl-alpha-L-arabinofuranosyl)-(1[*]5)-alpha-L-arabinofuranose
2,3,5-Tribenzoyl,picrate-beta-D-Ribazole|2,3,5-Tribenzoyl-alpha-D-Ribazole|2,3,5-Tribenzoyl-beta-D-Ribazole
23-alpha-D-glucuronopyranosyl-1,4-beta-D-xylotriose
O-(5-O-feruloyl-alpha-L-arabinofuranosyl)-(1-->3)-O-beta-D-xylopyranosyl-(1-->4)-D-xylopyranose|O-(5-O-feruloyl-alpha-L-arabinofuranosyl)-(1-3)-O-beta-D-xylopyranosyl-(1-4)-D-xylopyranose|O-<5-O-(trans-feruloyl)-alpha-L-arabinofuranosyl>-(1<*>3)-O-beta-D-xylopyranosyl-(1<*>4)-D-xylopyranose|O-[5-O-(E-feruloyl)-alpha-L-arabinofuranosyl](1->3)-O-beta-D-xylopyranosyl-(1->4)-D-xylopyranose
14-O-(4-Hydroxysenecioyl)isovernocistifolid-8-O-angelat
methyl 4,4-bis(6-((E)-3,4-dihydroxystyryl)-4-hydroxy-2-oxo-2H-pyran-3-yl)butanoate|phaeolschidin D
1beta,8beta-difuranoyl-4alpha,5alpha-dihydroxy-7beta,11-diacetoxydihydroagarofuran|triptersinine I
1beta,11beta-diacetoxy-4alpha,7beta-dihydroxy-5alpha,8beta-difuranoyldihydroagarofuran|triptersinine J
3-hydroxy-5-methylphenol 1-O-beta-D-(3,6-di-O-galloyl)glucopyranoside|cleyeratannin B
14-hydroxyhypocretenolide-beta-D-glucopyranoside tetraacetate
2-(3,4-Dihydroxyphenyl)-3,3,4,4-tetrahydro-3,3,5,7,7-pentahydroxy-2-(4-hydroxyphenyl)-4,6-bi[2H-1-benzopyran]-8-carboxylic acid
2-(3,4-Dihydroxyphenyl)-3,3,4,4-tetrahydro-3,3,5,7,7-pentahydroxy-2-(4-hydroxyphenyl)-4,8-bi[2H-1-benzopyran]-6-carboxylic acid
Asp Met Tyr Tyr
Asp Tyr Met Tyr
Asp Tyr Tyr Met
Met Asp Tyr Tyr
Met Tyr Asp Tyr
Met Tyr Tyr Asp
Tyr Asp Met Tyr
Tyr Asp Tyr Met
Tyr Met Asp Tyr
Tyr Met Tyr Asp
Tyr Tyr Asp Met
Tyr Tyr Met Asp
C-Pal
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D004791 - Enzyme Inhibitors
3'-O-Methylmaysin
4'-Hydroxyanigorootin
1,2,3,4-Tetra-O-acetyl-6-O-triphenylmethyl-beta-D-glucopyranose
Vorapaxar sulfate
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78274 - Agent Affecting Cardiovascular System
N-(4-chloro-2,5-dimethoxyphenyl)-2-[[2,5-dimethoxy-4-[(phenylamino)sulphonyl]phenyl]azo]-3-oxobutyramide
C26H27ClN4O8S (590.1238052000001)
2,6-Dimethylcarbonylphenyl-10-sulfopropylacridinium-9-carboxylate 4-NHS Ester
(R)-(E)-3-(2,6-dichloro-4-{4-[2-methyloxy-3-(1-hexyloxyethyl)phenyl]thiazol-2-ylcarbamoyl}phenyl)-2-methylacrylic acid
Cindunistat hydrochloride maleate
C20H39ClN6O8S2 (590.1959204000001)
C471 - Enzyme Inhibitor
Lusutrombopag
B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics C78275 - Agent Affecting Blood or Body Fluid
N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5R)-4-hydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-2-[(3R,4R,5R,6R)-4,5,6-trihydroxyoxan-3-yl]oxyoxan-3-yl]oxyoxane-2-carboxylic acid
4-Hydroxy-4-(11,16,18-trihydroxy-7-methoxycarbonyl-20-methyl-9,14,23-trioxo-6-oxahexacyclo[11.10.2.01,15.03,12.05,10.017,22]pentacosa-3,5(10),11,15,17(22),18,20,24-octaen-7-yl)butanoic acid
CGP 20712 A
C24H29F3N4O8S (590.1658110000001)
CGP 20712 A (CGP 20712 mesylate) is a highly selective β1-adrenoceptor antagonist with an IC50 of 0.7 nM. CGP 20712 A exhibits ~10,000-fold selectivity over β2-adrenoceptors[1].
3-hydroxy-3-methyl-5-oxo-5-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(2s)-5-hydroxy-6,8-dimethyl-4-oxo-2-phenyl-2,3-dihydro-1-benzopyran-7-yl]oxy}oxan-2-yl]methoxy}pentanoic acid
[3,4,5-tris(acetyloxy)-6-({2-methyl-10-methylidene-4,11-dioxo-12-oxatricyclo[7.3.1.0¹,⁵]trideca-2,5-dien-6-yl}methoxy)oxan-2-yl]methyl acetate
[(3r,4s,5s)-3,4-dihydroxy-5-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-[(5-methyl-2-oxochromen-4-yl)oxy]oxan-2-yl]methoxy}oxolan-3-yl]methyl 4-hydroxybenzoate
(2r,3s,4r)-2-{[(2s,3r,4r,5r,6r)-5-{[(2s,3s,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,4-dihydroxybutanoic acid
C21H38N2O17 (590.2170378000001)
(2r,3s,4s)-2-{[(2r,3r,4r,5r,6r)-5-{[(2s,3r,4s,5r,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-[(2s,3s,4s,5s)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,4-dihydroxybutanoic acid
C21H38N2O17 (590.2170378000001)